Your browser doesn't support javascript.
loading
Identification of novel HLA-restricted preferentially expressed antigen in melanoma peptides to facilitate off-the-shelf tumor-associated antigen-specific T-cell therapies.
Stanojevic, Maja; Hont, Amy B; Geiger, Ashley; O'Brien, Samuel; Ulrey, Robert; Grant, Melanie; Datar, Anushree; Lee, Ping-Hsien; Lang, Haili; Cruz, Conrad R Y; Hanley, Patrick J; Barrett, A John; Keller, Michael D; Bollard, Catherine M.
Affiliation
  • Stanojevic M; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA.
  • Hont AB; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA.
  • Geiger A; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA.
  • O'Brien S; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA.
  • Ulrey R; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA.
  • Grant M; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA.
  • Datar A; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA.
  • Lee PH; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA.
  • Lang H; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA.
  • Cruz CRY; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA; GW Cancer Center, George Washington University, Washington, DC, USA.
  • Hanley PJ; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA; GW Cancer Center, George Washington University, Washington, DC, USA; Division of Blood and Marrow Transplantation, Children's National Hospital, Washington, DC, USA.
  • Barrett AJ; GW Cancer Center, George Washington University, Washington, DC, USA.
  • Keller MD; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA; Division of Allergy and Immunology, Children's National Hospital, Washington, DC, USA.
  • Bollard CM; Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA; GW Cancer Center, George Washington University, Washington, DC, USA; Division of Blood and Marrow Transplantation, Children's National Hospital, Washington, DC, USA. Electronic address: cbollard@childrensna
Cytotherapy ; 23(8): 694-703, 2021 08.
Article in En | MEDLINE | ID: mdl-33832817
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukocytes, Mononuclear / Melanoma Type of study: Diagnostic_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: Cytotherapy Journal subject: TERAPEUTICA Year: 2021 Document type: Article Affiliation country: United States Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukocytes, Mononuclear / Melanoma Type of study: Diagnostic_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: Cytotherapy Journal subject: TERAPEUTICA Year: 2021 Document type: Article Affiliation country: United States Country of publication: United kingdom